T1	Participants 98 141	Heart Outcomes Prevention Evaluation (HOPE)
T2	Participants 261 308	patients at high risk for cardiovascular events
T3	Participants 369 545	death, myocardial infarction, stroke, coronary revascularization, cardiac arrest and heart failure, as well as the risk of diabetes-related complications and of diabetes itself
T4	Participants 758 785	reduction in blood pressure
